Marte Myhre Reigstad1, Inger Kristin Larsen2, Tor Åge Myklebust2, Trude Eid Robsahm2, Nan Birgitte Oldereid3, Louise A Brinton4, Ritsa Storeng5. 1. Norwegian National Advisory Unit on Women's Health and Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway; and martereigstad@gmail.com. 2. Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway; and. 3. Section for Reproductive Medicine, Department of Gynecology, Oslo University Hospital, Rikshospitalet, Oslo, Norway; 4. Division of Cancer Epidemiology & Genetics, Hormonal and Reproductive Epidemiology Branch, National Cancer Institute, Bethesda, Maryland. 5. Norwegian National Advisory Unit on Women's Health and.
Abstract
BACKGROUND AND OBJECTIVE: An increasing number of children are born after assisted reproductive technology (ART), and monitoring their long-term health effects is of interest. This study compares cancer risk in children conceived by ART to that in children conceived without. METHODS: The Medical Birth Registry of Norway contains individual information on all children born in Norway (including information of ART conceptions). All children born between 1984 and 2011 constituted the study cohort, and cancer data were obtained from the Cancer Registry of Norway. Follow-up started at date of birth and ended on the date of the first cancer diagnosis, death, emigration, or December 31, 2011. A Cox proportional hazards model was used to calculate hazard ratios (HR) and 95% confidence intervals (CI) of overall cancer risk between children conceived by ART and those not. Cancer risk was also assessed separately for all childhood cancer types. RESULTS: The study cohort comprised 1 628 658 children, of which 25 782 were conceived by ART. Of the total 4554 cancers, 51 occurred in ART-conceived children. Risk of overall cancer was not significantly elevated (HR 1.21; 95% CI 0.90-1.63). However, increased risk of leukemia was observed for children conceived by ART compared with those who were not (HR 1.67; 95% CI 1.02-2.73). Elevated risk of Hodgkin's lymphoma was also found for ART-conceived children (HR 3.63; 95% CI 1.12-11.72), although this was based on small numbers. CONCLUSIONS: This population-based cohort study found elevated risks of leukemia and Hodgkin's lymphoma in children conceived by ART.
BACKGROUND AND OBJECTIVE: An increasing number of children are born after assisted reproductive technology (ART), and monitoring their long-term health effects is of interest. This study compares cancer risk in children conceived by ART to that in children conceived without. METHODS: The Medical Birth Registry of Norway contains individual information on all children born in Norway (including information of ART conceptions). All children born between 1984 and 2011 constituted the study cohort, and cancer data were obtained from the Cancer Registry of Norway. Follow-up started at date of birth and ended on the date of the first cancer diagnosis, death, emigration, or December 31, 2011. A Cox proportional hazards model was used to calculate hazard ratios (HR) and 95% confidence intervals (CI) of overall cancer risk between children conceived by ART and those not. Cancer risk was also assessed separately for all childhood cancer types. RESULTS: The study cohort comprised 1 628 658 children, of which 25 782 were conceived by ART. Of the total 4554 cancers, 51 occurred in ART-conceived children. Risk of overall cancer was not significantly elevated (HR 1.21; 95% CI 0.90-1.63). However, increased risk of leukemia was observed for children conceived by ART compared with those who were not (HR 1.67; 95% CI 1.02-2.73). Elevated risk of Hodgkin's lymphoma was also found for ART-conceived children (HR 3.63; 95% CI 1.12-11.72), although this was based on small numbers. CONCLUSIONS: This population-based cohort study found elevated risks of leukemia and Hodgkin's lymphoma in children conceived by ART.
Authors: Marie Hargreave; Allan Jensen; Isabelle Deltour; Louise A Brinton; Klaus K Andersen; Susanne K Kjaer Journal: Int J Cancer Date: 2013-03-25 Impact factor: 7.396
Authors: Saswati Sunderam; Dmitry M Kissin; Sara Crawford; John E Anderson; Suzanne G Folger; Denise J Jamieson; Wanda D Barfield Journal: MMWR Surveill Summ Date: 2013-12-06
Authors: T J Keegan; K J Bunch; T J Vincent; J C King; K A O'Neill; G M Kendall; A MacCarthy; N T Fear; M F G Murphy Journal: Br J Cancer Date: 2013-04-23 Impact factor: 7.640
Authors: Carrie L Williams; Kathryn J Bunch; Charles A Stiller; Michael F G Murphy; Beverley J Botting; W Hamish Wallace; Melanie Davies; Alastair G Sutcliffe Journal: N Engl J Med Date: 2013-11-07 Impact factor: 91.245
Authors: Zuelma A Contreras; Johnni Hansen; Beate Ritz; Jorn Olsen; Fei Yu; Julia E Heck Journal: Cancer Epidemiol Date: 2017-07-14 Impact factor: 2.984
Authors: Ross E Anderson; Heidi A Hanson; William T Lowrance; Jeffrey Redshaw; Siam Oottamasathien; Anthony Schaeffer; Erica Johnstone; Kenneth I Aston; Douglas T Carrell; Patrick Cartwright; Ken R Smith; James M Hotaling Journal: J Urol Date: 2017-01-26 Impact factor: 7.450
Authors: Alberto Cárceles-Álvarez; Juan A Ortega-García; Fernando A López-Hernández; Mayra Orozco-Llamas; Blanca Espinosa-López; Esther Tobarra-Sánchez; Lizbeth Alvarez Journal: Environ Res Date: 2017-04-26 Impact factor: 6.498
Authors: Nady El Hajj; Larissa Haertle; Marcus Dittrich; Sarah Denk; Harald Lehnen; Thomas Hahn; Martin Schorsch; Thomas Haaf Journal: Hum Reprod Date: 2017-08-01 Impact factor: 6.918